Recent insights into atopic dermatitis and implications for management of infectious complications

Similar documents
Atopic Dermatitis and the Skin Barrier

NIH Public Access Author Manuscript J Invest Dermatol. Author manuscript; available in PMC 2014 April 01.

NIH Public Access Author Manuscript J Invest Dermatol. Author manuscript; available in PMC 2015 February 01.

Assessing the Current Treatment of Atopic Dermatitis: Unmet Needs

Barrier Function and Microbiotic Dysbiosis in Atopic Dermatitis. Mike Levin Division of asthma and allergy Department of paediatrics

Infectious Complications of Atopic dermatitis. Is AD a skin problem or an immune problem?

Microbial colonisation and canine atopic dermatitis. Dr Tim Nuttall RCVS Specialist in Veterinary Dermatology Head of Dermatology

Hot topics in Pediatric Dermatology. Yvonne Chiu, MD

Molecular mechanisms in atopic eczema - why do they ma6er in the clinic?

Inflammation in the clinic

What snewin atopicdermatitis. Dagmar Simon Universitätsklinik für Dermatologie, Inselspital, Universitätsspital Bern

Antimicrobial Peptides in Defense and Inflammatory Skin Diseases

Microbes and atopic dermatitis: The Yin and Yang of barrier and immune dysfunction

DNA vaccine, peripheral T-cell tolerance modulation 185

Cutaneous Immunology: Innate Immune Responses. Skin Biology Lecture Series

E-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling

Biologic Therapies for Atopic Dermatitis and Beyond

F036-Controversies in Vitamin D VITAMIN D AND ATOPIC DERMATITIS. Tissa Hata M.D. Professor, UCSD Department of Dermatology

Study. Kunal J. Khobragade GlaxoSmithKline Pharmaceuticals Ltd., Mumbai, India

The Skinny of the Immune System

Brick and mortar model of the SC 1,2 NORMAL SKIN BARRIER FUNCTION INTRODUCTION. Physical barrier 3. Structure of the skin. Chemical barrier 4-6

Scratching beneath the surface:

Contrasting pathogenesis of atopic dermatitis and psoriasis Part II: Immune cell subsets and therapeutic concepts

Defining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness

Vitamina D: un ormone multifunzione

Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis

Defining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness

Defining Asthma: Bronchial Hyperresponsiveness. Defining Asthma: Clinical Criteria. Impaired Ventilation in Asthma. Dynamic Imaging of Asthma

Airway Inflammation in Asthma Chih-Yung Chiu 1,2, Kin-Sun Wong 2 1 Department of Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan.

Positioning New Treatments for Atopic Dermatitis in Our Practice Parameter

Animal Models of Atopic Dermatitis

Atopic Dermatitis. Kong-Sang Wan, MD, PhD 温港生醫師台北市聯合醫院仁愛院區小兒科

Approach to eczema. Hugo Van Bever Department of Pediatrics NUHS - Singapore

Current reviews of allergy and clinical immunology (Supported by a grant from Astra Pharmaceuticals, Westborough, Mass)

Property of Presenter

Atopic Dermatitis: Emerging therapies. Melinda Gooderham MSc MD FRCPC

ANTIMICROBIAL PEPTIDES IN ATOPIC DERMATITIS ENDOGENOUS ANTIMICROBIAL PEPTIDES AND SKIN INFECTIONS IN ATOPIC DERMATITIS

An Update on Atopic Dermatitis

VITAMIN D AND THE SKIN JOYCE FARAH MD MS FAAD FARAH DERMATOLOGY AND COSMETICS, LLC ASSISTANT PROFESSOR OF MEDICINE AND ENT UPSTATE MEDICAL UNIVERSITY

BJD British Journal of Dermatology. Summary. What s already known about this topic? What does this study add? CLINICAL TRIAL

Staphylococcus aureus Colonization in Acute and Chronic Skin Lesions of Patients with Atopic Dermatitis

Environmental chemicals, Staphylococcus aureus, and antimicrobial resistance. NAS Workshop

The cutaneous innate immune response in patients with atopic dermatitis

5007 Seminar Advanced Therapeutics: Managing Severe & Refractory Eczema. Part 1. Keys to Adherence: Simplify regimen & Educate

Principles of Adaptive Immunity

The Beneficial Effect of Korean Red Ginseng Extract on Atopic Dermatitis Patients: An 8 Weeks Open, Noncomparative Clinical Study

Persistent food allergy might present a more challenging situation. Patients with the persistent form of food allergy are likely to have a less

The Genetics and Epigenetics of Atopic Dermatitis Filaggrin and Other Polymorphisms

Lessons Learned from the International Eczema Council (IEC)

Page # Lecture 8: Immune Dysfunction - Immunopathology. Four Types of Hypersensitivity. Friend of Foe? Autoimmune disease Immunodeficiency

Downloaded from:

Comorbid Infections of Pediatric Inflammatory Skin Diseases LeAnna Lane, MD; and Jonathan Dyer, MD

Basic Immunology. Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction

New insights into atopic dermatitis

Staphylococci. What s to be Covered. Clinical Scenario #1

Filaggrin Single Nucleotide Polymorphisms in Atopic Dermatitis

CANINE DIETARY AND ENVIRONMENTAL HYPERSENSITIVITY

Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases

Nitric Oxide-Releasing Topical Therapeutic for Atopic Dermatitis

What is atopic dermatitis?

Learning Objectives 10/26/2017. New Treatments in Atopic Dermatitis

A Yardstick for Managing Patients with Atopic Dermatitis

Summary. J.Q. Gong, L. Lin, T. Lin, F. Hao,* F.Q. Zeng, Z.G. Bi,à D. Yi* and B. Zhaoà

ATOPIC DERMATITIS: THE NEED FOR A SUB-SAHARAN PERSPECTIVE

The Role of Plasmacytoid Dendritic Cells in Psoriasis

Searching for Targets to Control Asthma

Pathogenesis of atopic dermatitis Donald Y. M. Leung, MD, PhD Denver, Colo Atopic dermatitis (AD) is a common inflammatory skin disease with increasin

Skin Immune Mechanisms in Health and Disease

UPDATES IN ATOPIC DERMATITIS

Immunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine

A functional probiotic Lactobacillus sakei probio-65 from kimchi for atopic eczemadermatitis

Severe Asthma Phenotypes in Children

Systemic treatment for moderate-to-severe atopic dermatitis? A systematic review and recommendation

USTEKINUMAB and BRIAKINUMAB

Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid

In parts 1 and 2 of this series on atopic dermatitis

Immunology Part II. Innate Immunity. 18. April 2018, Ruhr-Universität Bochum Marcus Peters,

The hands in health and disease of individuals with filaggrin loss-of-function mutations: clinical reflections on the hand eczema phenotype

EAACI Congress 2019 SCIENTIFIC PROGRAMME HIGHLIGHTS 1-5 JUNE Lisbon, Portugal

A. Incorrect! It s not correct. Synergism of cytokines refers to two or more cytokines acting together.

Role of staphylococcal superantigens in upper airway disease Claus Bachert, Nan Zhang, Joke Patou, Thibaut van Zele and Philippe Gevaert

What s to be Covered. Microbiology of staphylococci Epidemiology of S. aureus infections Pathogenesis of S. aureus infections

Pediatric Inflammatory Skin Disease Update. Inflammatory Skin Diseases. Factors influencing development of atopic dermatitis.

Novan Announces Promising Clinical Results with SB414

Genetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD

Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march

Pathogenesis and Management of Atopic Dermatitis

Introduction to Immunopathology

Atopic Dermatitis. Thomas Bieber, M.D., Ph.D.

Immunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine

Chapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group

Atopic Dermatitis INTRODUCTION. Thomas Bieber, M.D., Ph.D. INVITED REVIEW ARTICLE. Definition of atopy and atopic dermatitis.

and its clinical implications

Note: AD stands for Atopic Dermatitis. Page numbers in italics indicate figures. Page numbers followed by a t indicate tables.

Comparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis

Allergy overview. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital

Novan Provides Update on SB414 Inflammatory Skin Disease Development Program

Clinical Study Report Synopsis

Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist

Transcription:

Mark Boguniewicz, MD Professor, Division of Allergy-Immunology Department of Pediatrics National Jewish Health and University of Colorado School of Medicine Denver, Colorado USA Recent insights into atopic dermatitis and implications for management of infectious complications Increased susceptibility to infections or colonization with microbial organisms: Staphylococcus aureus, Herpes simplex Boguniewicz M, et al. J Allergy Clin Immunol 2010;125:4 1980 Hanifin & Rajka criteria for AD included tendency toward cutaneous infections 1

S. aureus adherence to normal healthy skin and uninvolved AD skin Cho S-H et al. J Allergy Clin Immunol 2001;108:269 Quantification of MSCRAMM* mutant S. aureus strains to uninvolved AD vs normal skin S. aureus bound/hpf 80 60 40 20 p <0.0001 p <0.0001 Fnbp - pos Fnbp - neg Clf - pos Clf - neg Cna - pos Cna - neg 0 Uninvolved AD Uninvolved Psoriasis Normal *microbial surface components recognizing adhesive matrix molecules Cho S-H, et al. J Allergy Clin Immunol 2001;108:269 A deficiency in antimicrobial peptide* (H-βdefensin-2) expression may allow S. aureus to colonize and infect skin of AD patients * keratinocytes are the major source of AMPs in the skin Ong PY, et al. N Engl J Med 2002;347:1151 2

Effects of IL-4 and IL-13 on TNF-α-induced H-β-defensin-2 expression in HaCat cells HBD-2 mrna (pg/ ng rrna) 15 10 5 g r p < 0.05 p < 0.05 0 Medium TNF-α IL-4 TNF-α + IL-4 IL-13 TNF-α + IL-4 + Ong PY, et al. N Engl J Med 2002;347:1151 IL-13 IL-4 and IL-13 inhibit cathelicidin expression through STAT-6 and can be reversed by neutralizing antibodies Howell MD, et al. Immunity 2006;24:341 Filaggrin deficiency and possible mechanisms of disease Irvine AD, et al. N Engl J Med 2011;365:1315 3

Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus Miajlovic H, et al. J Allergy Clin Immunol 2010;126:1184 Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus Miajlovic H, et al. J Allergy Clin Immunol 2010;126:1184 Genes contributing to skin barrier breakdown S.aureus colonization Cork MJ, et al. J Invest Dermatol 2009;129:1892 4

S. aureus extracellular protease causes epidermal barrier dysfunction ** *** ** V8 protease induced structural disturbance of the SC, including loss of corneodesmosome integrity & loss of corneocyte cohesion, arrows indicate corneodesmosomes ***V8 protease without occlusion induced increase in epidermal thickness, with occlusion, greater increase in epidermal thickness and inflammatory infiltrate in the dermis Hirasawa Y, et al. J Invest Dermatol 2010;130:614 S. aureus, toxins & AD Most AD pts colonized by toxin producing S. aureus Both MSSA & MRSA produce alpha-toxin critical for enhanced survival on skin ~ 10% of S. aureus isolates from AD pts shown to produce 2 superantigenic toxins (SEB & TSST) (coproduction not seen in isolates from >5000 pts with TSS) Use of topical steroids and TCIs may select for S. aureus strains that adapt to their new skin surface niche by increasing virulence capabilities AD pts make serve as an important reservoir for evolving S. aureus strains Schlievert PM, et al. J Allergy Clin Immunol 2010;125:39 T regulatory cells in atopic dermatitis and subversion of their activity by superantigens Ou LS, et al. J Allergy Clin Immunol 2004;113:756 5

Leung DYM. J Allergy Clin Immunol 2000;105:860 Virulence factor production by S. aureus Lowy FD. N Engl J Med 1998;339:520; Schlievert PM, et al. J Allergy Clin Immunol 2010;125:39 Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factoralpha from human keratinocytes Ezepchuk YV, et al. J Invest Dermatol 1996;107:603 6

Thymic stromal lymphopoietin: Master switch for allergic inflammation J Allergy Clin Immunol 2006;118 Phenotype of atopic dermatitis subjects with a history of eczema herpeticum AD patients with more polarized Th2-type disease with allergies and asthma and increased biomarkers including serum IgE, TSLP and cutaneous T cell-attracting chemokine more likely to have severe skin disease complicated by eczema herpeticum, S. aureus or molluscum infections Beck LA, et al. J Allergy Clin Immunol 2009;124:260 FLG mutations and Th2 polarization (Genetic variants in thymic stromal lymphopoietin are assocated with AD & EH) A critical link between barrier defect in AD patients with FLG mutations and Th2 polarization could be explained in part by enhanced allergen penetration through the damaged epidermis accompanied by increased production of TSLP* by keratinocytes leading to a Th2-type milieu * significant associations for TSLP and IL7R tagging SNPs and AD and ADEH in European Americans with replication of associations between TSLP and IL7R SNPs in an independent African American sample Gao P-S, et al. J Allergy Clin Immunol 2010;125:1403 7

Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2 Toll-like receptor 6 pathway Vu AT, et al. J Allergy Clin Immunol 2010;126:985 Boguniewicz M, et al. In Pediatric Allergy 2010; 566 NIAID Atopic Dermatitis Research Network 8